Amicus Therapeutics Inc (FOLD)
R&D Expense Growth
24.21%
Fiscal year · Period ending:
FOLD R&D Expense Growth
Latest reported24.21%period ending
Latest reported24.21%period ending
FOLD FY R&D Growth (YoY) (0.00% → 24.21%)
Latest values, visible window
High-resolution chart · PNG
FOLD r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 24.2141% | |
| -28.2312% | |
| -44.9246% | |
| 1.7012% | |
| -11.7993% | |
| 7.7049% | |
| 5.7128% | |
| 81.4359% | |
| 42.4809% | |
| 36.1956% | |
| 61.5635% | |
| 13.5419% | |
| -16.5675% | |
| -1.1464% | |
| 30.2597% | |
| -18.7995% | |
| 27.3197% | |
| 21.5293% | |
| -7.6011% | |
| 146.3459% | |
| 0% | |
| -100% | |
| 0% |